(Q44050731)

29 November 2017

title

Serial 1H-MRS in relapsing-remitting multiple sclerosis: effects of interferon-beta therapy on absolute metabolite concentrations (English)

1 reference

relapsing-remitting multiple sclerosis

29 November 2017

0 references

0 references

author name string

Florian Schubert

1

1 reference

29 November 2017

Frank Seifert

2

1 reference

29 November 2017

Clemens Elster

3

1 reference

29 November 2017

Alfred Link

4

1 reference

29 November 2017

Monika Walzel

5

1 reference

29 November 2017

Susanne Mientus

6

1 reference

29 November 2017

Judith Haas

7

1 reference

29 November 2017

Herbert Rinneberg

8

1 reference

29 November 2017

publication date

1 June 2002

1 reference

Magnetic Resonance Materials in Physics, Biology and Medicine

29 November 2017

published in

1 reference

29 November 2017

volume

14

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

213-222

1 reference

Reproducibility of 1H-MRS in vivo

29 November 2017

cites work

1 reference

12 December 2020

Quantitative MRS: comparison of time domain and time domain frequency domain methods using a novel test procedure.

1 reference

12 December 2020

Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients

1 reference

12 December 2020

Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient

1 reference

12 December 2020

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

1 reference

12 December 2020

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

12 December 2020

Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis

1 reference

12 December 2020

On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain

1 reference

12 December 2020

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

1 reference

12 December 2020

Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T

1 reference

12 December 2020

1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study

1 reference

12 December 2020

Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain

1 reference

12 December 2020

Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study

1 reference

12 December 2020

Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders.

1 reference

12 December 2020

The use of a priori knowledge to quantify short echo in vivo1h mr spectra

1 reference

12 December 2020

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions

1 reference

12 December 2020

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

12 December 2020

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.

1 reference

12 December 2020

Analysis of macromolecule resonances in 1H NMR spectra of human brain

1 reference

12 December 2020

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

1 reference

12 December 2020

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

12 December 2020

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

1 reference

12 December 2020

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

1 reference

12 December 2020

Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders

1 reference

12 December 2020

Chemical pathology of acute demyelinating lesions and its correlation with disability

1 reference

12 December 2020

Single-voxel proton MRS of the human brain at 1.5T and 3.0T.

1 reference

12 December 2020

10.1016/S1352-8661(02)00066-2

Identifiers

DOI

1 reference

29 November 2017

1 reference